akhatri

/akhatri

About akhatri

This author has not yet filled in any details.
So far akhatri has created 113 blog entries.

MHRA Drug Safety Update: Domperidone new contraindication

MHRA Drug Safety Update: Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension. The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension. [...]

The post MHRA Drug Safety Update: Domperidone new contraindication appeared first on Community Pharmacy England.

By |July 21st, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Domperidone new contraindication

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma)

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Macarthys Laboratories Ltd T/A Martindale Pharma) Drug alert number: EL(26)A/35 Date issued: 20 July 2026 Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in [...]

The post MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma) appeared first on Community Pharmacy England.

By |July 20th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma)

MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd)

MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd) Drug alert number: EL(26)A/34 Date issued: 13 July 2026 Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process. DMRC reference number: DMRC-40102707 Company name: [...]

The post MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd) appeared first on Community Pharmacy England.

By |July 13th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: ChloraPrep 1mL applicator (Beckton Dickson UK Ltd)

Medicine Supply Notification: Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free MSN/2026/031 Tier 2 – medium impact Date of issue: 9 July 2026 Latanoprost 50micrograms/ml / Timolol [0.5%] 5mg/ml (Fixapost®) preservative free eye drops, 0.2ml unit dose, are out of [...]

The post Medicine Supply Notification: Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free appeared first on Community Pharmacy England.

By |July 9th, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited)

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]

The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.

By |June 29th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited)